These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8222677)

  • 1. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.
    Yu M; Tomasa G
    Crit Care Med; 1993 Nov; 21(11):1635-42. PubMed ID: 8222677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole in the prevention of acute respiratory distress syndrome.
    DeVries A; Semchuk WM; Betcher JG
    Pharmacotherapy; 1998; 18(3):581-7. PubMed ID: 9620108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole prevents acute respiratory failure in critically ill surgical patients.
    Slotman GJ; Burchard KW; D'Arezzo A; Gann DS
    J Trauma; 1988 May; 28(5):648-54. PubMed ID: 3285017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.
    JAMA; 2000 Apr; 283(15):1995-2002. PubMed ID: 10789668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis.
    Sinuff T; Cook DJ; Peterson JC; Fuller HD
    J Crit Care; 1999 Mar; 14(1):1-6. PubMed ID: 10102717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in patients with severe adult respiratory distress syndrome treated with high-level positive end-expiratory pressure.
    DiRusso SM; Nelson LD; Safcsak K; Miller RS
    Crit Care Med; 1995 Sep; 23(9):1485-96. PubMed ID: 7664550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.
    Yu M; Levy MM; Smith P; Takiguchi SA; Miyasaki A; Myers SA
    Crit Care Med; 1993 Jun; 21(6):830-8. PubMed ID: 8504649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study.
    Pettilä V; Takkunen O; Varpula T; Markkola A; Porkka K; Valtonen V
    Crit Care Med; 2000 Nov; 28(11):3620-5. PubMed ID: 11098963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.
    Domenighetti G; Suter PM; Schaller MD; Ritz R; Perret C
    J Crit Care; 1997 Dec; 12(4):177-82. PubMed ID: 9459113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.
    Suter PM; Domenighetti G; Schaller MD; Laverrière MC; Ritz R; Perret C
    Chest; 1994 Jan; 105(1):190-4. PubMed ID: 8275731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
    Schuster DP; Metzler M; Opal S; Lowry S; Balk R; Abraham E; Levy H; Slotman G; Coyne E; Souza S; Pribble J;
    Crit Care Med; 2003 Jun; 31(6):1612-9. PubMed ID: 12794395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome.
    Bursten SL; Federighi DA; Parsons P; Harris WE; Abraham E; Moore EE; Moore FA; Bianco JA; Singer JW; Repine JE
    Crit Care Med; 1996 Jul; 24(7):1129-36. PubMed ID: 8674324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 67gallium-transferrin pulmonary leak index in patients at risk for the acute respiratory distress syndrome.
    Groeneveld AB; Raijmakers PG
    Crit Care Med; 1998 Apr; 26(4):685-91. PubMed ID: 9559605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial.
    Abraham E; Park YC; Covington P; Conrad SA; Schwartz M
    Crit Care Med; 1996 Jan; 24(1):10-5. PubMed ID: 8565513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole to prevent acute respiratory distress syndrome in critically ill patients.
    Frazee LA; Neidig JA
    Ann Pharmacother; 1995; 29(7-8):784-6. PubMed ID: 8520099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective trial of high-frequency oscillation in adults with acute respiratory distress syndrome.
    Mehta S; Lapinsky SE; Hallett DC; Merker D; Groll RJ; Cooper AB; MacDonald RJ; Stewart TE
    Crit Care Med; 2001 Jul; 29(7):1360-9. PubMed ID: 11445688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis.
    Suchner U; Katz DP; Fürst P; Beck K; Felbinger TW; Senftleben U; Thiel M; Goetz AE; Peter K
    Crit Care Med; 2001 Aug; 29(8):1569-74. PubMed ID: 11505129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial.
    Villar J; Kacmarek RM; Pérez-Méndez L; Aguirre-Jaime A
    Crit Care Med; 2006 May; 34(5):1311-8. PubMed ID: 16557151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
    Domenighetti G; Stricker H; Waldispuehl B
    Crit Care Med; 2001 Jan; 29(1):57-62. PubMed ID: 11176161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.